GlassScriptPhysician profile
Theodore S Pabst
NPI 1508967563
$9,991.94
in general payments reported to CMS, 2019-2025
26 companies · $2,440 in 2025
The $2,440 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $874 · 2020: $97.30 · 2021: $1,553 · 2022: $374 · 2023: $3,770 · 2024: $884 · 2025: $2,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,172 · Travel and Lodging: $1,884 · Education: $37.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,171.99 |
| Travel and Lodging | $1,883.50 |
| Education | $37.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,057.54 | 2023-2025 | Abre, Ellipsys Vascular Access System, In.Pact Av |
| Endologix LLC | $1,998.93 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Inari Medical, INC. | $1,350.64 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $1,346.69 | 2019-2025 | Eluvia, Jetstream Sc, Peripheral Rotalink Plus |
| Abbott Laboratories | $456.02 | 2023-2025 | Esprit, Starclose Se, Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $364.33 | 2019-2025 | Crosser Iq, Rotarexs 6 F X 135 Cm, Venclose Maven Catheter |
| W. L. Gore & Associates, INC. | $350.96 | 2019-2023 | Gore Viabahn Endoprosthesis |
| Philips North America LLC | $197.20 | 2023-2025 | Labosys, Igt Devices Undivided, (Br8) Peripheral Thrombectomy |
| Medtronic Vascular, INC. | $162.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $143.53 | 2019-2023 | Xarelto |
| Shape Memory Medical INC. | $79.55 | 2024 | Impede Embolization Plug |
| Cordis US Corp. | $65.41 | 2023-2024 | Brite Tip Radianz, Radial 360 |
| Vasorum USA INC. | $60.93 | 2023 | Celt Acd |
| Angiodynamics, INC. | $51.39 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $46.10 | 2024 | Penumbra System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $44.59 | 2023-2025 | Xenosure Biologic Patch, Flexcel Carotid Shunt |
| Asahi Intecc USA, INC. | $35.72 | 2025 | Asahi Peripheral Vascular Wires |
| Venclose INC. | $35.04 | 2020 | |
| Surmodics, INC. | $23.05 | 2024 | Pounce Thrombectomy System |
| Otsuka America Pharmaceutical, INC. | $22.20 | 2023 | Jynarque |
| Siemens Medical Solutions USA, INC. | $21.30 | 2022 | |
| Cardiovascular Systems INC. | $20.73 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.45 | 2025 | Nuzyra |
| Advanced Oxygen Therapy INC. | $13.55 | 2023 | Topical Oxygen Chamber For Extremities |
| Mimedx Group, INC. | $13.35 | 2024 | |
| Terumo Medical Corporation | $13.11 | 2023 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Pabst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.